Beijing Yadong Biopharmaceutical

Beijing Yadong Biopharmaceutical is a prominent Chinese pharmaceutical company headquartered in the Daxing District of Beijing. Established in 1994, the firm specializes in the research, development, and large-scale production of both Traditional Chinese Medicine (TCM) and chemical pharmaceuticals. The company's extensive product portfolio is particularly recognized for its focus on pediatrics and respiratory health, featuring flagship products such as Xiaoer Kechuanling Granules and various anti-influenza medications. Operating from a modern, GMP-certified manufacturing base, Beijing Yadong Biopharmaceutical integrates advanced extraction technologies with rigorous quality control standards. It maintains a strong market presence across China, positioning itself as a key contributor to the modernization of herbal medicine and the supply of essential chemical drugs. The company continues to expand its reach through a comprehensive network of R&D, production, and domestic sales operations.